Announcements

World Children’s Day was first established in 1954 as Universal Children’s Day and is celebrated on 20 November each year to promote international co-operation, awareness among children worldwide, and improvements in their welfare. This year, under the theme “Listen to the Future, Stand up for Children’s Rights”, we were honored to interview Dr. Anna Di Sessa, a Section Board Member of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383).

The following is a short interview with Dr. Anna Di Sessa:

1. Could you introduce yourself and share a brief overview of your research field?
I am a pediatrician with a specialized focus on endocrinology and nephrology, currently practicing at the Pediatric Clinic of the University of Campania “Luigi Vanvitelli”. In January 2020, I earned a PhD in translational medicine from the same institution. Since 2011, my research has primarily concentrated on childhood obesity and its cardiometabolic consequences, particularly focusing on metabolic dysfunction-associated steatotic liver disease (MASLD) and kidney damage. 

2. What is the biggest challenge you have faced in your research career?
One of the key challenges I have faced was bridging the gap between research findings and their practical application in clinical settings. In pediatrics, while new treatments or interventions may demonstrate promising results in clinical trials, translating these findings into routine practice often encounters significant barriers. These include limitations in healthcare infrastructure, cost considerations, and resistance to adopting new practices among clinicians.
Additionally, conducting research with vulnerable populations, such as children, introduces ethical complexities. Ensuring that studies adhere to high ethical standards while protecting participants’ well-being and privacy requires meticulous planning and ongoing ethical reflection.

3. What does World Children’s Day mean to you, both as a researcher and as a member of the global community?
World Children’s Day serves as a crucial reminder of our collective responsibility to safeguard and prioritize the health, rights, and well-being of children. As a researcher, it underscores the need to address the unique health challenges children face through evidence-based research. On a broader scale, it emphasizes the importance of creating a world where all children can thrive, free from poverty, violence, and neglect. It is both a call to advance research focused on child health and to advocate for policies that protect and empower children globally.

4. Looking ahead, what changes or advancements would you most like to see in the next 10 years to ensure a safer, healthier, and more equitable future for all children?
In the next decade, I hope to see substantial progress in pediatric care, particularly through the integration of personalized medicine. By tailoring treatments to a child’s unique genetic profile, environmental factors, and lifestyle, personalized medicine has the potential to substantially enhance the precision and efficacy of interventions, particularly for complex conditions such as rare diseases, cancers, and chronic illnesses. The broader adoption of telemedicine and AI-driven diagnostic tools could also improve access to care, especially in underserved regions. Furthermore, there should be a heightened focus on pediatric mental health, alongside the development of global policies that ensure universal access to quality education, clean water, nutrition, and protection from harm. These advancements hold the promise of fostering a safer, healthier, and more equitable future for children worldwide.

5. As a Section Board Member of JCM, could you share your experience with MDPI?
As a Section Board Member of JCM, my experience with MDPI has been highly productive and rewarding. MDPI offers a robust platform for open access publishing, ensuring a transparent and efficient peer-review process. Working with MDPI has allowed me to contribute to the strategic direction of the journal, particularly in advancing clinical medicine while maintaining rigorous research standards. The editorial support and global reach provided by MDPI have facilitated the rapid dissemination of research, especially in specialized fields such as pediatrics. Their commitment to innovation and quality has significantly enhanced the visibility and impact of JCM.

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Academic Editorial Board meeting at the EASD 2025 on 16 September 2025 in Vienna, Austria. Six Editorial Board Members attended. As a premier event for staying abreast of the latest advancements in diabetes research and practice, EASD 2025 provided an ideal platform for this engagement. During the conference, we met our Section Editor-in-Chief, Prof. Dr. Didac Mauricio, and other scholars with whom we have cooperated for many years. We look forward to reconnecting with you at future international conferences to explore opportunities for deeper collaboration. We invite you to revisit the wonderful highlights of this event.

At our booth, we received positive feedback from scholars, who expressed satisfaction with their collaboration with us and a willingness to continue working with us. We are pleased to share some photos taken with scholars at our booth.

From left to right: Prof. Dr. Didac Mauricio and Nemanja Perovic (MDPI); Nemanja Perovic (MDPI), Dr. Alfredo Caturano, and Silvija Seles (MDPI).

At the Academic Editorial Board meeting, we provided a brief overview of JCM’s basic information and played a journal-produced promotional video. This video highlighted JCM’s scope, academic achievements, and role in the academic publishing landscape. The following key highlights were discussed in the meeting: (1) To increase the Impact Factor of the journal, Members suggested revising the scope of the journal and its Sections and conducting an analysis of the Impact Factor “per Section”. (2) New proposals and suggestions for peer review models were discussed. (3) Members felt we should share the metrics of the journal’s rejection rate and the evolution of objective metrics that are proof of quality (indexing in major databases, IFs, CiteScore values, and the outreach of publications). (4) It was suggested that we should advertise the awards we are granting to researchers. (5) Numerous suggestions were proposed regarding external collaborations, such as partnering with major institutions, exploring conference sponsorships and collaborations with academic societies, and deepening cooperation with young scholars. (6) Views were exchanged on the use of AI tools in research, and we shared some information about MDPI's initiatives in this area. (7) Members expressed interest in our proposal to “assist them in organizing their events,” and we will explore possibilities for expanding our collaboration model in the future.

Attendee list of Academic Editorial Board Meeting (in no particular order):

• Prof. Dr. Heinrich Resch, Section Board Member, Academic Teaching Hospital of the University Vienna, School of Medicine, University Vienna, Austria;
• Prof. Dr. Catharina Chiari, Guest Editor, Department of Pediatric Orthopedics and Foot Surgery, Orthopedic Hospital Speising, Austria;
• Prof. Dr. Katrin Bekes, Guest Editor, Department of Pediatric Dentistry, Medical University of Vienna, Austria;
• Dr. Ilias Migdalis, Guest Editor, Director of Diabetes Centre, Lefkos Stavros Hospital, Greece;
• Prof. Dr. Vilma Urbančič-Rovan, Guest Editor, ¹ Department of Endocrinology, University Medical Centre, University of Ljubljana, Ljubljana, Slovenia; ² Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia;
• Dr. Elias K. Spanakis, Guest Editor, Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, USA.

In addition, to explore highly cited papers on the topic of diabetes, please click here. Do not miss our conference column, where you can find information about the journal’s conferences.

We look forward to our continued collaboration. We are happy to accept your suggestions and feedback, so please feel free to contact the JCM Editorial Office via email at jcm@mdpi.com.

On behalf of the Editors-in-Chief, Prof. Dr. Emmanuel Andrès and Prof. Dr. Kent Doi, we wish to acknowledge our Guest Editors who established Special Issues in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) by presenting an award to the Special Issues that will be closed in 2026. Three Special Issues will receive the award. The Special Issues will be selected after a thorough evaluation by the journal Award Committee, led by the Editor-in-Chief. 

Eligibility for the Award:

• Special Issues that will be closed in 2026;
• Special Issues with more than 15 published papers.

Selection criteria:
The Special Issues will be selected by the journal Award Committee according to the following criteria:

• The alignment of the Special Issues and their publications with the journal’s aim and scope;
• Number of papers published;
• The visibility and influence of the Special Issue, including citations, downloads, and overall engagement.

Prize:

• CHF 500;
• An opportunity to publish a paper free of charge in JCM after peer review;
• A certificate.

Number of winners: 3.

The winners will be announced on the journal website at the end of March 2027.

JCM Editorial Office

Conference: Pharmacology 2025
Date: 16–18 December 2025
Location: Belfast, UK

MDPI will be attending Pharmacology 2025 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

The British Pharmacological Society’s annual “Pharmacology” conference brings together individuals from across academia, healthcare, industry and the regulatory sector to share and celebrate the latest research and developments in pharmacology and its related subject areas. The conference is a great opportunity for those studying and working to attend lectures from experts and emerging researchers, network and socialise, and showcase your own work.

The following open access journals will be represented:

• Future Pharmacology;
• Journal of Personalized Medicine;
• Journal of Clinical Medicine;
• Sclerosis;
• Scientia Pharmaceutica;
• Pharmacoepidemiology;
• Biomedicines;
• Psychoactives;
• Medicines;
• Journal of Pharmaceutical and BioTech Industry;
• Drugs and Drug Candidates.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.miceconciergeme.com/pharmacology2025.

We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2025, 92% of our authors rate the peer review as good or excellent, thanks to our pool of excellent reviewers. 

One of our exceptional reviewers captures the spirit of this community perfectly:
“I review out of passion for research and scientific dialogue. JCM’s open access approach and user-friendly format support thorough, meaningful peer review.”
This sentiment reflects the commitment and scholarly engagement that drives our peer-review process forward.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in the journal’s peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable. 

The Exceptional Reviewers List was introduced in 2025. Each quarter, we will be selecting a group of outstanding reviewers and announcing them here. 

Q4:

Name: Dr. Hyunjung Koh
Affiliation: The Catholic University of Korea, College of Medicine, Seoul, South Korea
Interests: postoperative pain; knee replacement arthroplasties; bupivacaine; brachial plexus anesthesia; nerve block

Name: Dr. Maria Rogalidou
Affiliation: Division of Gastroenterology & Hepatology, First Paediatrics Department,
National & Kapodistrian University of Athens, Agia Sofia Children's Hospital, Athens, Greece
Interests: paediatrics; pediatric gastroenterology; hepatology and nutrition; inflammatory bowel disease; celiac disease; H. Pylori infection; eosinophilic disorders of GI; MAFLD; AIH liver disease; pediatric endoscopy

Name: Dr. Peter Wahl
Affiliations: ¹ Endo-Team, Birshof Hospital, Muenchenstein, Switzerland
² Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland; ³ ARTORG Center, Faculty of Medicine, University of Bern, Bern, Switzerland
Interests: orthopedics; traumatology; hip; arthroplasty; revision; infection; polyethylene; corrosion

Name: Dr. Bernardo Dias Pereira
Affiliation: Endocrinology and Nutrition Service, Divino Espírito Santo Hospital of Ponta Delgada, EPER, Ponta Delgada, Azores, Portugal
Interests: thyroid cytology; molecular endocrinology; monogenic diabetes mellitus; genetics of endocrine diseases; endocrine oncology; pituitary

Name: Dr. Aleksandra Bryndal
Affiliation: Department of Physiotherapy, Institute of Health Sciences, Pomeranian University, Poland
Interests: neurophysiology, physiotherapy, spinal overload, electromyography

Q3:

Name: Dr. Nagib Salloum Dahdah
Affiliation: CHU Sainte-Justine—Le centre hospitalier universitaire mere-enfant, Division of Pediatric Cardiology, Montreal, Canada
Interests: Kawasaki disease; pediatric cardiology, coronary revascularization 

Name: Dr. Chun-Hou Liao
Affiliation: Division of Urology, Department of Surgery, Cardinal Tien Hospital, Taipei, Taiwan College of Medicine, Fu-Jen Catholic University, Taipei, Taiwan
Interests: prostate cancer; urology 

Name: Dr. Andy Yen-Tung Teng
Affiliations: ¹ Center for Osteoimmunology and Biotechnology Research (COBR), School of Dentistry, College of Dental Medicine, Kaohsiung Medical University (KMU) & KMU-Hospital, Kaohsiung 80708, Taiwan; ² Laboratory of Molecular Microbial Immunity, Division of Periodontology, The Eastman Institute for Oral Health (EIOH), School of Medicine and Dentistry, University of Rochester, Rochester, NY 14620, USA
Interests: periodontology, oral microbiology, and immunology 

Name: Dr. Shona Goldsmith
Affiliation: Cerebral Palsy Alliance Research Institute, Discipline of Child and Adolescent Health, The University of Sydney, Sydney, Australia
Interests: cerebral palsy; child and adolescent health; physiotherapy 

Name: Dr. Romulo Leão S. Silva Neris
Affiliation: Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Interests: immunology; inflammation; viruses; virus infection 

Q2:

Name: Dr. Arieh Eden
Affiliation: Carmel Medical Center, Haifa, Israel
Interests: mechanical ventilation; critical care medicine; sepsis; anesthesiology 

Name: Dr. Frank-Mattias Schäfer
Affiliation: Department of Pediatric Surgery and Pediatric Urology, Cnopfsche Kinderklinik, Nürnberg, Germany
Interests: pediatric urology; pediatric surgery 

Name: Dr. Sveinung Wergeland Sørbye
Affiliation: Department of Clinical Pathology, University Hospital of North Norway, 9006 Tromsø, Norway
Interests: cancer immunology; prognostic markers; cervical cancer screening and prevention 

Name: Dr. Filipe Gonzalez
Affiliation: Critical Department, Hospital Garcia de Orta E.P.E, Almada, Portugal
Interests: hemodynamic monitoring; echocardiography; intensive care 

Name: Dr. Amanda J. Boyle
Affiliation: Centre for Addiction and Mental Health, Toronto, Canada
Interests: PET imaging; radiopharmaceuticals; neuroinflammatory; neurodegenerative diseases; oncology biomarkers 

Q1:

Name: Dr. Shehzad Rehman
Affiliation: OHSU School of Medicine, Portland, United States
Interests: nephrology and hypertension; transplantation

Name: Dr. Nicolas Johner
Affiliation: Cardiology Division, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, Switzerland
Interests: cardiology; atrial fibrillation; cardiac electrophysiology; electrocardiography; pacemakers 

Name: Dr. Matthew Bottomley
Affiliation: Oxford Kidney and Transplant Unit, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Interests: nephrology; immunological biomarker; organ transplant 

Name: Dr. Kristin Keller
Affiliation: Hospital Universitario 12 de Octubre, Madrid, Spain
Interests: nutrition and dietetics; abdominal obesity; metabolism 

Name: Dr. Masashi Mizuguchi
Affiliation: The University of Tokyo, Tokyo, Japan
Interests: child neurology; pediatrics; developmental neuroscience

The Academic Editorial Board Meeting of  Journal of Clinical Medicine (JCM, ISSN: 2077-0383) was held at the EADV Congress 2025 on 17 September. We sincerely appreciate the academic communication platform provided by the EADV Congress 2025. We were able to meet with Editorial Board Members at our booth and also successfully welcomed three members to our academic meeting, despite their busy schedules. We cordially invite you to join us in reviewing the highlights of this event.

We engaged in productive interactions with 11 Editorial Board Members at our booth, receiving extensive positive feedback while meticulously documenting and addressing each question raised. Our consistent commitment to delivering high-quality publishing services has gained broad recognition among Board Members, most of whom explicitly support the open access model. Our distinct advantages were widely acknowledged to be our short publication cycles and the prompt responsiveness of our editorial team. Additionally, the Editorial Board Members expressed support for our initiative to participate in this booth exchange, which further strengthened their trust in us.

Notably, the Editorial Board Members showed keen interest in the awards we have established. Some Members also proactively suggested deeper collaboration with the journal through organizing seminars at universities and conducting author training sessions. We expressed our willingness to actively pursue these opportunities. We look forward to establishing multifaceted collaborations with relevant scholars, institutions, and affiliated associations. This will not only help elevate the journal's visibility and influence but also better serve the medical community, advancing the dissemination and development of knowledge within the field of clinical medicine. We are pleased to share some photos of interactions with scholars at the booth. 

From left to right and top to bottom: Denisa Madalina Grozav (MDPI) and Prof. Dr. Konstantin Krasagakis; Dr. Andrea Carugno and Denisa Madalina Grozav (MDPI); Dr. Ziad Khamaysi and Denisa Madalina Grozav (MDPI); Dr. Shany Sherman and Denisa Madalina Grozav (MDPI)

Secondly, during our Academic Editorial Board meeting, we presented a multi-dimensional overview of the journal, covering the following aspects: an introduction to the journal, our performance data, some of our highly cited papers, an overview of hot research topics, and the country distribution of our authors and Editorial Board Members, as well as marketing activities, Special Issue Collections, and social media account information.

The following key highlights were covered in the meeting:

First, members provided feasible suggestions on the word count, type, and APC for manuscripts. Second, proposals were made to strengthen full-process oversight in Special Issue operations while refining thematic planning and promotion strategies to enhance the quality and appeal of Special Issues. Third, emphasis was placed on rigorously vetting reviewer qualifications during peer review and improving reviewer incentive mechanisms to ensure review efficiency and quality. Additionally, regarding journal promotion, the importance of social media promotion was underscored, with a suggestion to introduce diverse interview-based content to enrich promotional formats.

Below are two photos of the meeting flyer and the room set-up.

The photos of the meeting flyer and room set-up.

Attendees of the Academic Editorial Board Meeting (in no particular order):

• Dr. Drew Kuraitis, Section Board Member, Department of Dermatology, Roswell Park Comprehensive Cancer Center, USA;
• Dr. Norbert Kiss, Topical Advisory Panel Member/ Guest Editor, Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Hungary;
• Dr. Péter Holló, Guest Editor, Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Hungary.

In addition, we welcome you to join our online conference, The 3rd International Online Conference on Clinical Medicine, which will be held from 17 to 19 November 2025 (CET), online. The goal of this conference is to enable scientists to present their latest research in the field of clinical medicine and engage in discussions with the global scientific community. We invite scientists, researchers, and healthcare professionals to contribute to and share their findings in the following areas, including but not limited to cardiology and cardiovascular medicine; nephrology and urology; emergency medicine; nuclear medicine and radiology; general surgery; clinical rehabilitation; pulmonology; and anesthesiology.

Conference: Multiomics and Precision Medicine Joint Conference 2025
Date: 8–9 November 2025
Place: Taipei, Taiwan

We are excited to announce that MDPI will be attending the Multiomics and Precision Medicine Joint Conference 2025 (MOPM 2025) as an exhibitor and proud sponsor of the Special Poster Award Sponsorship, which will recognize six recipients of the MDPI Rising Star Poster Awards.

Now in its seventh edition, MOPM serves as Taiwan’s leading academic platform dedicated to integrative multiomics and precision medicine research. Organized jointly by six major scientific societies, the conference promotes interdisciplinary collaboration across life sciences, medicine, and data science.

This year’s theme, “Big Data and AI Revolution for Next-Generation Precision Medicine”, will highlight cutting-edge applications of artificial intelligence and big data in biotechnology and healthcare. The program will feature plenary talks from international experts, poster presentations, industry showcases, and exhibitions of the latest research and technologies — fostering dialogue and collaboration among scholars and professionals across disciplines.

The following MDPI journals will be represented:

• Proteomes;
• Sclerosis;
• Metabolites;
• Biomolecules;
• Cancers;
• Cells;
• Journal of Clinical Medicine (JCM);
• Journal of Personalized Medicine (JPM);
• Pharmaceuticals.

If you will be attending this conference, our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.mopmtaiwan.com.

MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.

About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.

Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.

About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) held its Editorial Board meeting for the Section “Emergency Medicine”, which was hosted by the Section Editor-in-Chief, Prof. Dr. Michael Christ. Currently, the “Emergency Medicine” Section has 25 Editorial Board members. Due to scheduling constraints, five members attended this meeting. During the session, the attending members conducted in-depth face-to-face discussions focusing on the Section’s current status and future development directions and put forward valuable insights to support the Section’s development. We are extremely grateful for the strong support of our members, and we warmly welcome all members to actively participate in future Editorial Board meetings. We also cordially invite members to visit our booth during academic conferences where both parties participate, to engage in discussions and interactions, thereby fostering academic collaboration and knowledge sharing within the emergency medicine field in the future.

Our journal’s announcement column regularly shares conference updates, and our official social media accounts also feature such information to keep you updated on the latest journal collaboration news. We remain open to suggestions for service improvement, warmly welcome scholars to recommend new conferences or provide advice and invite you to contact the JCM Editorial Office (jcm@mdpi.com).

The key highlights of this Editorial Board Meeting are recapitulated as follows:

• The journal’s history and publication statistics;
• The journal’s marketing activities, including conference booths, webinars, and collaborations with societies;
• The publication status of the Emergency Medicine Section over the past three years, as well as the keywords of highly cited papers and the Special Issue project.

The following information was covered in the members’ discussion:

• Define Core Objectives: Publishing high-quality papers;
• Optimize Peer-Review Mechanisms: Propose multiple constructive improvement plans to further ensure the fairness and professionalism of the review process, providing a scientific basis for selecting high-quality research outcomes;
• Strengthen Conference Promotion: Expand multi-channel publicity for academic conferences to enhance industry visibility and influence, building a broader platform for scholarly exchange;
• Precise Planning of Special Issues: Developing themed Special Issues with unique features;
• Harness Collective Wisdom for Sustainable Development: Advocate for all members to collaboratively build a dedicated online document for this academic sub-division, clarifying departmental objectives and editorial standards. This collective effort will provide robust support for the sub-division’s long-term development.

Attendee list (in no particular order):

• Prof. Dr. Michael Christ (Section Editor-in-Chief), Emergency Department, Luzerner Kantonsspital, Luzern, Switzerland;
• Prof. Dr. Marcello Covino, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore, Rome, Italy;
• Prof. Dr. Giorgio Costantino, U.O.C. Pronto Soccorso e Medicina D’Urgenza, IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy;
• Dr. Andrea Fabbri, Emergency Department, AUSL della Romagna, Forli, Italy;
• Prof. Dr. Alexander Oskar Spiel, ¹ Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria; ² Department of Emergency Medicine, Wilheminenspital, Vienna, Austria.

To access more information about the Section, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Emergency_Med. In addition, you can find highly cited papers and hot-topic Special Issues in the “Emergency Medicine” Section via the following link: https://www.mdpi.com/journal/jcm/announcements/12876.